Treating mammalian subject sensitive to indomethacin ulcerogenis

Details Treating mammalian subject sensitive to indomethacin ulcerogenis Treating mammalian subject sensitive to indomethacin ulcerogenis

1978-08-08

1980-04-29

Rosen, Sam

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

424274, A61K 3162, A61K 31405

Patent

active

042006317

ABSTRACT:
Ulcer production in animals is prevented during prolonged antiphlogistic treatment with ulcerogenic quantities of indomethacin by using it in a composition of 1 part of indomethacin to 7.5 to 25 parts, preferably 10 parts by weight of a salicylate. Indomethacin is the most potent ulcerating compound among approved non-steroid antiinflammatory agents.

REFERENCES:
Hultmark et al.-Chem. Abst. vol. 83 (1975), p. 141,706k.
Gietka et al.-Chem. Abst. vol. 82 (1975), p. 291p.

Affiliated with

Also associated with

Rating

Treating mammalian subject sensitive to indomethacin ulcerogenis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating mammalian subject sensitive to indomethacin ulcerogenis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating mammalian subject sensitive to indomethacin ulcerogenis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1684004